TY - JOUR
T1 - Noninvasive diagnostic imaging for endometriosis part 2
T2 - a systematic review of recent developments in magnetic resonance imaging, nuclear medicine and computed tomography
AU - Avery, Jodie C.
AU - Knox, Steven
AU - Deslandes, Alison
AU - Leonardi, Mathew
AU - Lo, Glen
AU - Wang, Hu
AU - Zhang, Yuan
AU - Holdsworth-Carson, Sarah Jane
AU - Thi Nguyen, Tran Tuyet
AU - Condous, George Stanley
AU - Carneiro, Gustavo
AU - Hull, Mary Louise
AU - Imagendo Study Group
AU - O'Hara, Rebecca
AU - Panuccio, Catrina
AU - Sirop, Aisha
AU - Abbott, Jason
AU - Gonzalez-Chica, David
AU - Chen, Tim
AU - To, Minh Son
AU - Yang, Natalie
AU - Uzuner, Cansu
AU - Freger, Shay
AU - Abeygunasekara, Nimantha
AU - Richards, Misha
AU - Simpson, Annie
AU - Voyvodic, Frank
AU - Jenkins, Melissa
PY - 2024/2
Y1 - 2024/2
N2 - Endometriosis affects 1 in 9 women, taking 6.4 years to diagnose using conventional laparoscopy. Non-invasive imaging enables timelier diagnosis, reducing diagnostic delay, risk and expense of surgery. This review updates literature exploring the diagnostic value of specialist endometriosis magnetic resonance imaging (eMRI), nuclear medicine (NM) and computed tomography (CT). Searching after the 2016 IDEA consensus, 6192 publications were identified, with 27 studies focused on imaging for endometriosis. eMRI was the subject of 14 papers, NM and CT, 11, and artificial intelligence (AI) utilizing eMRI, 2. eMRI papers describe diagnostic accuracy for endometriosis, methodologies, and innovations. Advantages of eMRI include its: ability to diagnose endometriosis in those unable to tolerate transvaginal endometriosis ultrasound (eTVUS); a panoramic pelvic view, easy translation to surgical fields; identification of hyperintense iron in endometriotic lesions; and ability to identify super-pelvic lesions. Sequence standardization means eMRI is less operator-dependent than eTVUS, but higher costs limit its role to a secondary diagnostic modality. eMRI for deep and ovarian endometriosis has sensitivities of 91-93.5% and specificities of 86-87.5% making it reliable for surgical mapping and diagnosis. Superficial lesions too small for detection in larger capture sequences, means a negative eMRI doesn't exclude endometriosis. Combined with thin sequence capture and improved reader expertise, eMRI is poised for rapid adoption into clinical practice. NM labeling is diagnostically limited in absence of suitable unique marker for endometrial-like tissue. CT studies expose the reproductively aged to radiation. AI diagnostic tools, combining independent eMRI and eTVUS endometriosis markers, may result in powerful capability. Broader eMRI use, will optimize standards and protocols. Reporting systems correlating to surgical anatomy will facilitate interdisciplinary preoperative dialogues. eMRI endometriosis diagnosis should reduce repeat surgeries with mental and physical health benefits for patients. There is potential for early eMRI diagnoses to prevent chronic pain syndromes and protect fertility outcomes.
AB - Endometriosis affects 1 in 9 women, taking 6.4 years to diagnose using conventional laparoscopy. Non-invasive imaging enables timelier diagnosis, reducing diagnostic delay, risk and expense of surgery. This review updates literature exploring the diagnostic value of specialist endometriosis magnetic resonance imaging (eMRI), nuclear medicine (NM) and computed tomography (CT). Searching after the 2016 IDEA consensus, 6192 publications were identified, with 27 studies focused on imaging for endometriosis. eMRI was the subject of 14 papers, NM and CT, 11, and artificial intelligence (AI) utilizing eMRI, 2. eMRI papers describe diagnostic accuracy for endometriosis, methodologies, and innovations. Advantages of eMRI include its: ability to diagnose endometriosis in those unable to tolerate transvaginal endometriosis ultrasound (eTVUS); a panoramic pelvic view, easy translation to surgical fields; identification of hyperintense iron in endometriotic lesions; and ability to identify super-pelvic lesions. Sequence standardization means eMRI is less operator-dependent than eTVUS, but higher costs limit its role to a secondary diagnostic modality. eMRI for deep and ovarian endometriosis has sensitivities of 91-93.5% and specificities of 86-87.5% making it reliable for surgical mapping and diagnosis. Superficial lesions too small for detection in larger capture sequences, means a negative eMRI doesn't exclude endometriosis. Combined with thin sequence capture and improved reader expertise, eMRI is poised for rapid adoption into clinical practice. NM labeling is diagnostically limited in absence of suitable unique marker for endometrial-like tissue. CT studies expose the reproductively aged to radiation. AI diagnostic tools, combining independent eMRI and eTVUS endometriosis markers, may result in powerful capability. Broader eMRI use, will optimize standards and protocols. Reporting systems correlating to surgical anatomy will facilitate interdisciplinary preoperative dialogues. eMRI endometriosis diagnosis should reduce repeat surgeries with mental and physical health benefits for patients. There is potential for early eMRI diagnoses to prevent chronic pain syndromes and protect fertility outcomes.
KW - computed tomography
KW - diagnosis
KW - Endometriosis
KW - magnetic resonance imaging
KW - nuclear medicine
UR - http://www.scopus.com/inward/record.url?scp=85184046083&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2023.12.017
DO - 10.1016/j.fertnstert.2023.12.017
M3 - Review article
AN - SCOPUS:85184046083
SN - 0015-0282
VL - 121
SP - 189
EP - 211
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 2
ER -